Low-Dose Azacitidine (AZA) for Treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapse after Allogeneic Hematopoietic Cell Transplant (HCT) by Ueda, Masumi, MD, Lazarus, Hillard M., MD, Cooper, Brenda, MD, Caimi, Paolo, MD, Creger, Richard, PharmD, Little, Jane A., MD, Baer, Linda, CNP, Brister, Lauren, CNP, AOCNP, Malek, Ehsan, MD, Metheny, Leland, MD, Tomlinson, Benjamin, MD, Gerson, Stan L., MD, Oran, Betul, MD, de Lima, Marcos, MD

Get full text